Biolidics chairman to step down at later date amid search for replacement
Add BT as a preferred source
Sharanya Pillai
DeeperDive is a beta AI feature. Refer to full articles for the facts.
GAVIN Mark McIntyre, the independent chairman of Catalist-listed Biolidics , will leave his post on Nov 30 – instead of Friday (Sep 29), as previously announced when he resigned.
This will give Biolidics’ board and nominating committee more time to identify and appoint one or more suitable replacements, the company said in a bourse filing on Friday. Besides chairing the board, McIntyre also chairs its audit committee.
The additional time will allow for a smooth handover of duties, and comes at the request of the other members of the board, Biolidics added.
Separately, the company is also seeking a new sponsor, as announced on Thursday. United Overseas Bank has terminated its continuing sponsorship agreement with the company, citing “commercial reasons”.
Biolidics shares ended Friday at S$0.014, up 7.7 per cent or S$0.001.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Air India asks Tata, Singapore Airlines for funds after US$2.4 billion loss
Beijing’s calculated silence on the Iran war
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant
